Beranda › Leukemia Mieloid Akut › Iowa › Cedar Rapids
Uji klinis Leukemia Mieloid Akut di Cedar Rapids, IA
16 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar Cedar Rapids (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauhnya
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Menerima pesertaFase 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauhnya
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauhnya
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauhnya
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Menerima pesertaFase 3
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauhnya
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Menerima pesertaFase 1/2
- University of Iowa Hospital, Iowa City · 25 mi jauhnya
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Menerima pesertaStudi observasional
- University of Iowa Hospital and Clinics, Iowa City · 25 mi jauhnya
High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
Menerima pesertaFase 1
- University of Iowa Health Care, Iowa City · 25 mi jauhnya
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Menerima pesertaFase 1/2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauhnya
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Menerima pesertaFase 3
- University of Iowa Stead Family Children's Hospital, Iowa City · 25 mi jauhnya
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Menerima pesertaFase 3
- University of Iowa, Iowa City · 25 mi jauhnya
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Menerima pesertaFase 1
- University of Iowa Hospitals & Clinics, Iowa City · 25 mi jauhnya
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Menerima pesertaFase 3
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi jauhnya
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Menerima pesertaStudi observasional
- University of Iowa, Iowa City · 25 mi jauhnya
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Menerima pesertaFase 1
- University of Iowa Hospitals & Clinics, Iowa City · 25 mi jauhnya
Uji klinis Leukemia Mieloid Akut di kota lain
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Baldwin Park, CA40 studi
- Seattle, WA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA30 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Studi lain di Cedar Rapids
- Kanker Paru Non-Sel Kecil20 studi
- Kanker Payudara17 studi
- Kanker (semua jenis)15 studi
- Mieloma Multipel15 studi
- Kanker Paru14 studi
- Kanker Kolorektal13 studi
- Kanker Prostat12 studi
- Karsinoma Sel Skuamosa Kepala dan Leher12 studi
- Melanoma10 studi
- Stroke10 studi
- Kanker Metastatik9 studi
- Kanker Endometrium9 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.